MoneyWorks4Me

RPG Life Sciences - Quaterly Results

01 Feb 2024 Evaluate
The Revenue for the quarter ended  December 2023 of Rs. 1537.00 millions grew by 17.69 % from Rs. 1306.00 millions.Net Profit recorded in the quarter ended December 2023 rise to 38.46% to Rs. 264.60  millions  compared to R. 191.10 millions in corresponding previous quarter.OP of the company witnessed a marginal growth to 398.20 millions from 297.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1537.00 1306.00 17.69 4550.60 3943.20 15.40 5128.10 4401.60 16.51
Other Income 19.20 5.10 276.47 55.60 29.60 87.84 48.00 29.90 60.54
PBIDT 398.20 297.20 33.98 1129.90 897.40 25.91 1074.90 893.50 20.30
Interest 1.40 0.70 100.00 3.10 2.60 19.23 3.10 5.20 -40.38
PBDT 396.80 296.50 33.83 1126.80 894.80 25.93 1071.80 888.30 20.66
Depreciation 41.40 39.10 5.88 125.80 116.10 8.35 155.00 156.60 -1.02
PBT 355.40 257.40 38.07 1001.00 778.70 28.55 916.80 731.70 25.30
TAX 90.80 66.30 36.95 256.80 205.80 24.78 240.40 216.90 10.83
Deferred Tax -4.20 -2.90 44.83 -14.10 -0.80 1662.50 -3.10 -10.70 -71.03
PAT 264.60 191.10 38.46 744.20 572.90 29.90 676.40 514.80 31.39
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 25.91 22.76 13.85 24.83 22.76 9.10 20.96 20.30 3.26
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..